Stenex International (SXI) Q2 2026: Grid and Fast-Growth Markets Drive 28% Revenue Mix Shift
Stenex International’s Q2 results mark a structural inflection in organic growth, propelled by grid and fast-growth market penetration that now accounts for 28% of sales. Strategic capacity expansions and new product launches are translating into record order intake, while management signals continued investment to sustain growth despite near-term margin plateauing. Investors should focus on execution in grid, capacity ramp timing, and evolving end-market demand as Stenex reiterates its multi-year growth trajectory.
Summary
- Grid and Fast-Growth Markets Surge: Over one-quarter of sales now stem from grid, defense, space, and EVs, reflecting a decisive business mix shift.
- Capacity Expansion in Focus: Multi-site investments in Croatia, Mexico, and Houston will more than double grid capacity over three to five years.
- Margin Plateau as Growth Investment Grows: Near-term segment margin upside is capped as resources are redeployed to sustain expansion and customer demand.
Performance Analysis
Stenex delivered a 16.6% year-on-year revenue increase, with organic growth of 6.4% and the remainder driven by acquisitions and currency. Electronics, the largest segment, grew 20.6% (11.1% organic), with a book-to-bill ratio of 1.08 and record $125 million orders—underscoring robust demand from grid and new product channels. Engraving and Engineering Technologies rebounded with double-digit organic growth, while Scientific and Specialty Solutions lagged due to end-market softness and NIH funding constraints.
Adjusted operating margin expanded to 19%, up 30 basis points, as higher volume and product mix offset incremental growth investments and medical costs. Free cash flow improved sharply ($13 million vs $2.2 million prior year), supporting continued debt paydown and a 6.3% dividend increase. Net leverage sits at 2.3x EBITDA, with management emphasizing further deleveraging through FY26.
- Electronics Orders Signal Multi-Quarter Visibility: Book-to-bill above 1.0 for six straight quarters; grid sub-segment at 1.2, indicating sustained backlog conversion.
- New Products Fuel Top-Line: $16.3 million in Q2 new product sales, up 13%, with FY26 target raised to $85 million.
- Fast-Growth Markets Now 28% of Mix: Up from partial-year 184 million to projected $270 million+, with grid alone representing over half of this revenue.
Segment-level analysis reveals electronics and grid as margin leaders, but near-term profit upside is muted by upfront costs of capacity expansions in Croatia, Mexico, and Houston. Specialty Solutions remains a drag, with management citing North American market weakness but expecting sequential improvement.
Executive Commentary
"We recorded 6.4% organic growth and a book-to-bill ratio of 1.04, led by our electronics segment, which grew 11.1% organically with a book-to-bill ratio of 1.08. The contributions from sales into fast-growth markets, new product sales, and improving general industrial markets are now evident in our results."
David Dunbar, Chairman, President and CEO
"Our book-to-bill for the electronics in total was over one, with the grid business being at about 1.2 book-to-bill and the core business being at about 1.03, 1.04. Orders in the electronics business have been strong over the past two quarters."
Ademir Sarcevic, Chief Financial Officer and Treasurer
Strategic Positioning
1. Grid Business and Fast-Growth Market Penetration
Grid, instrument transformer and related power infrastructure, now anchors Stenex’s growth strategy, comprising over half of fast-growth market sales. The Ameren and Orion acquisitions provide global reach and customer intimacy, with OEMs increasingly outsourcing to Stenex for speed, quality, and cost advantages. Management reports that customer-driven expansion requests are fueling the multi-site capacity buildout, with Croatia, Mexico, Houston, and India sites expected to more than double capacity within five years.
2. New Product Development Flywheel
R&D investment ramped from 1% to 3% of sales since FY21, now manifesting in a robust pipeline—nine launches to date, four in Q2, with >15 planned for FY26. Engineering Technologies and Engraving segments benefit from proprietary process wins (e.g., soft trim in automotive), while space commercialization and defense represent outsized new product growth. Management raised new product sales guidance, reflecting confidence in innovation’s role as a growth lever.
3. Capacity Expansion and Margin Dynamics
Capacity expansion is a double-edged sword: near-term drag on segment margins due to upfront staffing and site setup, but critical for long-term share gain in grid and related markets. Management is clear that margin would be higher absent these investments, but this would limit ability to capture accelerating customer demand. Lean, automation, and site diversification are expected to unlock operating leverage as volumes scale.
4. M&A and Portfolio Strategy
Deleveraging creates headroom for targeted acquisitions, especially in grid and adjacent electronics. Management is actively building a pipeline in instrument transformers and broader components/modules, with customer input guiding targets. Space market M&A is also on the radar, reflecting an intent to capitalize on secular trends beyond grid.
5. Geographic and End-Market Diversification
Asia and Europe are growth engines for legacy switches and relays, while North America remains weak. Defense, space, and EVs are emerging as incremental contributors to the fast-growth mix, providing end-market resilience and optionality as traditional industrial cycles remain uneven.
Key Considerations
This quarter’s results reflect Stenex’s transition from strategic positioning to execution in high-growth, high-margin markets. The company’s ability to balance growth investments with margin discipline, and to convert record backlog into sustainable revenue, will define its multi-year trajectory.
Key Considerations:
- Grid Capacity Execution Risk: Timely ramp of Croatia, Mexico, and Houston is essential to meet customer demand and sustain margin leadership.
- Order Backlog Conversion: Long conversion cycles in customized electronics require operational discipline to translate bookings into revenue and cash flow.
- Specialty Solutions and Scientific Headwinds: Weak North American demand and NIH funding cuts continue to weigh on these segments, offsetting broader growth.
- Margin Plateau as Growth Investments Scale: Near-term margin upside is capped as resources are redeployed to support site launches and customer-driven expansions.
- M&A Pipeline and Integration: Further acquisitions in grid/components or space could accelerate growth, but integration and cultural alignment remain critical.
Risks
Execution risk is elevated around capacity ramp and integration of recent and future acquisitions. Macro uncertainty, especially in North America and specialty end-markets, could pressure overall growth rates. Tariff and trade policy shifts remain a wildcard, particularly as the company leverages India and EU supply chains. NIH funding volatility and cyclical industrial demand could further impact Scientific and Specialty Solutions segments.
Forward Outlook
For Q3 2026, Stenex guided to:
- Mid to high single-digit organic revenue growth, driven by fast-growth markets and new product sales
- Slightly higher adjusted operating margin, with volume and mix offset by growth investments and medical costs
For full-year 2026, management reiterated guidance:
- Revenue growth exceeding $110 million over FY25, with new product sales raised to $85 million and fast-growth market sales to exceed $270 million
Management highlighted several factors that shape the outlook:
- Continued strong order intake in grid and electronics supports multi-quarter visibility
- Capacity expansions and new product launches are expected to drive incremental growth, but margin upside is moderated by investment ramp
Takeaways
Stenex is shifting its revenue base toward higher-growth, higher-margin markets while investing heavily in capacity and innovation. The company’s ability to deliver on expansion plans, convert backlog, and offset segment-specific headwinds will be closely watched by investors.
- Grid and Fast-Growth Markets Anchor Growth: Over half of fast-growth revenue now comes from grid, with defense and space scaling as new vectors.
- Capacity Expansion is a Strategic Imperative: Management is prioritizing long-term share gain over near-term margin, accepting investment drag to secure customer-driven growth.
- Execution in Backlog Conversion and M&A Will Define Trajectory: Investors should monitor progress in site ramps, order conversion, and disciplined acquisition integration as the story unfolds.
Conclusion
Stenex International’s Q2 2026 results confirm a business model pivot toward high-value, secular growth markets, powered by grid and new product innovation. Management’s disciplined capacity and portfolio strategy, balanced with near-term margin tradeoffs, positions the company for multi-year growth—contingent on flawless execution and end-market resilience.
Industry Read-Through
Stenex’s results offer a clear signal for industrials and electronics peers: customer-driven outsourcing of grid and power infrastructure components is accelerating, favoring firms with scale, speed, and engineering depth. Capacity expansion and geographic diversification are becoming table stakes for suppliers to global OEMs, while the ability to rapidly commercialize new products is increasingly a differentiator. End-market cyclicality remains a challenge in North America and scientific research, but secular trends in electrification, defense, and space commercialization are providing offsetting tailwinds. Investors in the sector should watch for similar margin tradeoffs as peers invest to capture share in fast-growth verticals.